ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $320,183 | -19.2% | 10,443 | -2.6% | 0.00% | – |
| Q2 2023 | $396,071 | -38.3% | 10,722 | -32.2% | 0.00% | – |
| Q4 2022 | $642,084 | +19.8% | 15,811 | +21.7% | 0.00% | – |
| Q3 2022 | $536,000 | +44.1% | 12,989 | +18.0% | 0.00% | – |
| Q2 2022 | $372,000 | -12.1% | 11,007 | +18.5% | 0.00% | – |
| Q1 2022 | $423,000 | -45.8% | 9,290 | -18.3% | 0.00% | – |
| Q4 2021 | $780,000 | +21.3% | 11,374 | +9.0% | 0.00% | – |
| Q3 2021 | $643,000 | -28.8% | 10,435 | -4.3% | 0.00% | – |
| Q2 2021 | $903,000 | +20.7% | 10,908 | -7.0% | 0.00% | – |
| Q1 2021 | $748,000 | -60.1% | 11,728 | -49.9% | 0.00% | -100.0% |
| Q4 2020 | $1,874,000 | +238.9% | 23,407 | +96.3% | 0.00% | – |
| Q3 2020 | $553,000 | -22.3% | 11,922 | -24.5% | 0.00% | -100.0% |
| Q2 2020 | $712,000 | +56.8% | 15,794 | -6.6% | 0.00% | 0.0% |
| Q1 2020 | $454,000 | -77.4% | 16,912 | -46.7% | 0.00% | 0.0% |
| Q4 2019 | $2,013,000 | +370.3% | 31,743 | +109.8% | 0.00% | – |
| Q3 2019 | $428,000 | +16.0% | 15,131 | +8.7% | 0.00% | – |
| Q2 2019 | $369,000 | +1504.3% | 13,924 | +1013.9% | 0.00% | – |
| Q1 2019 | $23,000 | -82.7% | 1,250 | -88.3% | 0.00% | – |
| Q4 2018 | $133,000 | -60.9% | 10,678 | -39.7% | 0.00% | – |
| Q3 2018 | $340,000 | +30.3% | 17,696 | -8.3% | 0.00% | – |
| Q2 2018 | $261,000 | +57.2% | 19,290 | -15.8% | 0.00% | – |
| Q1 2018 | $166,000 | +67.7% | 22,900 | -14.3% | 0.00% | – |
| Q4 2017 | $99,000 | +70.7% | 26,706 | +98.1% | 0.00% | – |
| Q3 2017 | $58,000 | – | 13,478 | +5291.2% | 0.00% | – |
| Q2 2017 | $0 | – | 250 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 250 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 250 | -98.9% | 0.00% | – |
| Q3 2016 | $166,000 | +8200.0% | 22,502 | +4355.8% | 0.00% | – |
| Q2 2016 | $2,000 | – | 505 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |